BIOTECH SOLUTIONS FOR
We develop preventive treatment for infections in fish that replace antibiotics, improve survival rates and boost natural immunity.
Healthier fish, healthier environment, healthier you.
Antibiotics overuse is a silent threat: 80% of them are used in animal production and create super-resistant bacteria that also attack people
The WHO predicted that in 2050 more people will die from super-resistant bacteria than cancer (50 million vs 10 million)
Climate change is accelerating this path by reactivating ancient bacteria due to warmer conditions.
Bacterial infections cause 6 billion annual losses in this industry and 40% fish die before harvest
to reproduce a key protein in fish that boosts natural immunity. In Chilean Salmon we achieved:
No withdrawal period needed
Protection against its two main fish pathogens
No harmful inflammatory process for fish to overcome infections
The Sustainability Prize of the Aquaculture Challenge by The Yield Lab
Successful bioassay trials with 70% survival rate in trials independently carried out by Abbott Labs
we aim for more
Our platform will expand to identify proteins for key physiological processes in different species and protect our One Health.
WHO INVESTED IN US_
GridX and CORFO have already trusted our initiative with pre seed investment and grants. Meanwhile Abbott labs and By Bug are active allies in I+D.
WHAT ROUND OF INVESTMENT ARE WE CURRENTLY IN_
We are in a seed stage, seeking to gather investment to scale up production and develop a bioinformatic platform for new products.
ARE WE PROFITABLE_
The market today is at 73 billion USD. And aquaculture’s annual growth rate of 6% will generate profits exceeding USD 208.9 billion USD, by 2025.
Despite its rising importance as a healthy and low environmental impact source of proteins, there are still no cost effective and sustainable solutions for the diseases that attack farmed fish. Our solution is cost effective and friendly with the environment.
We want to lead global aquaculture health through biotechnological innovations and groundbreaking solutions that increase sustainability, productivity, and animal welfare while protecting human health and the environment.
Jorn Bethke – CTO
Daniela Allerbon – CEO
Cristián Valenzuela – CSO